Frankfurt - Delayed Quote EUR

PHAXIAM Therapeutics S.A. (2E40.F)

Compare
1.7200
-0.0100
(-0.58%)
At close: January 31 at 9:48:30 PM GMT+1
All numbers in thousands
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
45,811.0000
66,768.0000
80,402.0000
Total Liabilities Net Minority Interest
22,325.0000
43,923.0000
53,863.0000
Total Equity Gross Minority Interest
23,486.0000
22,845.0000
26,539.0000
Total Capitalization
31,033.0000
38,077.0000
40,918.0000
Common Stock Equity
23,486.0000
22,845.0000
26,539.0000
Capital Lease Obligations
3,455.0000
9,979.0000
10,804.0000
Net Tangible Assets
23,481.0000
22,830.0000
25,950.0000
Working Capital
30,956.0000
20,043.0000
20,285.0000
Invested Capital
33,598.0000
38,241.0000
43,183.0000
Tangible Book Value
23,481.0000
22,830.0000
25,950.0000
Total Debt
13,567.0000
25,375.0000
27,448.0000
Share Issued
3,101.8550
3,101.8550
2,005.7560
Ordinary Shares Number
3,101.6050
3,101.6050
2,005.5060
Treasury Shares Number
0.2500
0.2500
0.2500
12/31/2020 - 4/18/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade